(MSTR) MicroStrategy - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US5949724083
Stock:
Total Rating 11
Risk 72
Buy Signal -1.07
| Risk 5d forecast | |
|---|---|
| Volatility | 97.3% |
| Relative Tail Risk | -7.53% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.51 |
| Alpha | -70.91 |
| Character TTM | |
|---|---|
| Beta | 1.513 |
| Beta Downside | 0.307 |
| Drawdowns 3y | |
|---|---|
| Max DD | 77.42% |
| CAGR/Max DD | 0.97 |
EPS (Earnings per Share)
Revenue
Risks
Technicals:
volatile
Description: MSTR MicroStrategy
Strategy Inc, together with its subsidiaries, operates as a bitcoin treasury company in the United States, Europe, the Middle East, Africa, and internationally. The company offers investors varying degrees of economic exposure to Bitcoin by offering a range of securities, including equity and fixed income instruments. It also provides AI-powered enterprise analytics software, including Strategy One, which provides non-technical users with the ability to directly access novel and actionable insights for decision-making; and Strategy Mosaic, a universal intelligence layer that offers enterprises with consistent definitions and governance across data sources, regardless of where that data resides or which tools access it. The company was formerly known as MicroStrategy Incorporated and changed its name to Strategy Inc in August 2025. The company was incorporated in 1989 and is headquartered in Tysons Corner, Virginia.
Piotroski VR‑10 (Strict, 0-10) 1.0
| Net Income: -4.03b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.32 > 0.02 and ΔFCF/TA 54.09 > 1.0 |
| NWC/Revenue: 441.6% < 20% (prev -22.24%; Δ 463.9% < -1%) |
| CFO/TA -0.00 > 3% & CFO -45.6m > Net Income -4.03b |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 5.62 > 1.5 & < 3 |
| Outstanding Shares: last quarter (294.0m) vs 12m ago 32.67% < -2% |
| Gross Margin: 68.69% > 18% (prev 0.72%; Δ 6797 % > 0.5%) |
| Asset Turnover: 1.09% > 50% (prev 1.79%; Δ -0.70% > 0%) |
| Interest Coverage Ratio: -84.00 > 6 (EBITDA TTM -5.43b / Interest Expense TTM 65.0m) |
Altman Z'' 0.35
| A: 0.03 (Total Current Assets 2.56b - Total Current Liabilities 456.5m) / Total Assets 61.64b |
| B: 0.10 (Retained Earnings 6.32b / Total Assets 61.64b) |
| C: -0.12 (EBIT TTM -5.46b / Avg Total Assets 43.74b) |
| D: 0.60 (Book Value of Equity 6.32b / Total Liabilities 10.60b) |
| Altman-Z'' Score: 0.35 = B |
Beneish M -2.96
| DSRI: 1.10 (Receivables 205.7m/181.2m, Revenue 477.2m/463.5m) |
| GMI: 1.05 (GM 68.69% / 72.06%) |
| AQI: 0.97 (AQ_t 0.96 / AQ_t-1 0.99) |
| SGI: 1.03 (Revenue 477.2m / 463.5m) |
| TATA: -0.06 (NI -4.03b - CFO -45.6m) / TA 61.64b) |
| Beneish M-Score: -2.96 (Cap -4..+1) = A |
What is the price of MSTR shares?
As of February 27, 2026, the stock is trading at USD 133.40 with a total of 18,042,025 shares traded.
Over the past week, the price has changed by +3.05%, over one month by -16.93%, over three months by -24.05% and over the past year by -49.33%.
Over the past week, the price has changed by +3.05%, over one month by -16.93%, over three months by -24.05% and over the past year by -49.33%.
Is MSTR a buy, sell or hold?
MicroStrategy has received a consensus analysts rating of 4.31.
Therefore, it is recommended to buy MSTR.
- StrongBuy: 7
- Buy: 5
- Hold: 0
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the MSTR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 396 | 196.9% |
| Analysts Target Price | 396 | 196.9% |
MSTR Fundamental Data Overview February 21, 2026
P/E Forward = 1.1078
P/S = 90.1281
P/B = 1.0082
P/EG = 3.09
Revenue TTM = 477.2m USD
EBIT TTM = -5.46b USD
EBITDA TTM = -5.43b USD
Long Term Debt = 8.17b USD (from longTermDebt, two quarters ago)
Short Term Debt = 31.3m USD (from shortTermDebt, last quarter)
Debt = 8.28b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.98b USD (from netDebt column, last quarter)
Enterprise Value = 48.99b USD (43.01b + Debt 8.28b - CCE 2.30b)
Interest Coverage Ratio = -84.00 (Ebit TTM -5.46b / Interest Expense TTM 65.0m)
EV/FCF = -2.52x (Enterprise Value 48.99b / FCF TTM -19.46b)
FCF Yield = -39.73% (FCF TTM -19.46b / Enterprise Value 48.99b)
FCF Margin = -4078 % (FCF TTM -19.46b / Revenue TTM 477.2m)
Net Margin = -844.8% (Net Income TTM -4.03b / Revenue TTM 477.2m)
Gross Margin = 68.69% ((Revenue TTM 477.2m - Cost of Revenue TTM 149.4m) / Revenue TTM)
Gross Margin QoQ = 66.11% (prev 70.46%)
Tobins Q-Ratio = 0.79 (Enterprise Value 48.99b / Total Assets 61.64b)
Interest Expense / Debt = 0.13% (Interest Expense 11.1m / Debt 8.28b)
Taxrate = 21.0% (US default 21%)
NOPAT = -4.31b (EBIT -5.46b * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 5.62 (Total Current Assets 2.56b / Total Current Liabilities 456.5m)
Debt / Equity = 0.16 (Debt 8.28b / totalStockholderEquity, last quarter 51.04b)
Debt / EBITDA = -1.10 (negative EBITDA) (Net Debt 5.98b / EBITDA -5.43b)
Debt / FCF = -0.31 (negative FCF - burning cash) (Net Debt 5.98b / FCF TTM -19.46b)
Total Stockholder Equity = 48.26b (last 4 quarters mean from totalStockholderEquity)
RoA = -9.22% (Net Income -4.03b / Total Assets 61.64b)
RoE = -8.35% (Net Income TTM -4.03b / Total Stockholder Equity 48.26b)
RoCE = -9.67% (EBIT -5.46b / Capital Employed (Equity 48.26b + L.T.Debt 8.17b))
RoIC = -8.26% (negative operating profit) (NOPAT -4.31b / Invested Capital 52.17b)
WACC = 9.65% (E(43.01b)/V(51.29b) * Re(11.49%) + D(8.28b)/V(51.29b) * Rd(0.13%) * (1-Tc(0.21)))
Discount Rate = 11.49% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 26.49%
[DCF] Fair Price = unknown (Cash Flow -19.46b)
EPS Correlation: 21.80 | EPS CAGR: -12.16% | SUE: -3.96 | # QB: 0
Revenue Correlation: -30.01 | Revenue CAGR: 0.82% | SUE: 0.25 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-15.66 | Chg7d=+0.000 | Chg30d=-17.543 | Revisions Net=+0 | Analysts=1
EPS current Year (2026-12-31): EPS=72.17 | Chg7d=+0.000 | Chg30d=+27.373 | Revisions Net=+3 | Growth EPS=+573.9% | Growth Revenue=+3.5%
EPS next Year (2027-12-31): EPS=43.12 | Chg7d=+0.000 | Chg30d=-15.490 | Revisions Net=+1 | Growth EPS=-40.2% | Growth Revenue=-2.3%
[Analyst] Revisions Ratio: +0.60 (4 Up / 1 Down within 30d for Current Year)
P/S = 90.1281
P/B = 1.0082
P/EG = 3.09
Revenue TTM = 477.2m USD
EBIT TTM = -5.46b USD
EBITDA TTM = -5.43b USD
Long Term Debt = 8.17b USD (from longTermDebt, two quarters ago)
Short Term Debt = 31.3m USD (from shortTermDebt, last quarter)
Debt = 8.28b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.98b USD (from netDebt column, last quarter)
Enterprise Value = 48.99b USD (43.01b + Debt 8.28b - CCE 2.30b)
Interest Coverage Ratio = -84.00 (Ebit TTM -5.46b / Interest Expense TTM 65.0m)
EV/FCF = -2.52x (Enterprise Value 48.99b / FCF TTM -19.46b)
FCF Yield = -39.73% (FCF TTM -19.46b / Enterprise Value 48.99b)
FCF Margin = -4078 % (FCF TTM -19.46b / Revenue TTM 477.2m)
Net Margin = -844.8% (Net Income TTM -4.03b / Revenue TTM 477.2m)
Gross Margin = 68.69% ((Revenue TTM 477.2m - Cost of Revenue TTM 149.4m) / Revenue TTM)
Gross Margin QoQ = 66.11% (prev 70.46%)
Tobins Q-Ratio = 0.79 (Enterprise Value 48.99b / Total Assets 61.64b)
Interest Expense / Debt = 0.13% (Interest Expense 11.1m / Debt 8.28b)
Taxrate = 21.0% (US default 21%)
NOPAT = -4.31b (EBIT -5.46b * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 5.62 (Total Current Assets 2.56b / Total Current Liabilities 456.5m)
Debt / Equity = 0.16 (Debt 8.28b / totalStockholderEquity, last quarter 51.04b)
Debt / EBITDA = -1.10 (negative EBITDA) (Net Debt 5.98b / EBITDA -5.43b)
Debt / FCF = -0.31 (negative FCF - burning cash) (Net Debt 5.98b / FCF TTM -19.46b)
Total Stockholder Equity = 48.26b (last 4 quarters mean from totalStockholderEquity)
RoA = -9.22% (Net Income -4.03b / Total Assets 61.64b)
RoE = -8.35% (Net Income TTM -4.03b / Total Stockholder Equity 48.26b)
RoCE = -9.67% (EBIT -5.46b / Capital Employed (Equity 48.26b + L.T.Debt 8.17b))
RoIC = -8.26% (negative operating profit) (NOPAT -4.31b / Invested Capital 52.17b)
WACC = 9.65% (E(43.01b)/V(51.29b) * Re(11.49%) + D(8.28b)/V(51.29b) * Rd(0.13%) * (1-Tc(0.21)))
Discount Rate = 11.49% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 26.49%
[DCF] Fair Price = unknown (Cash Flow -19.46b)
EPS Correlation: 21.80 | EPS CAGR: -12.16% | SUE: -3.96 | # QB: 0
Revenue Correlation: -30.01 | Revenue CAGR: 0.82% | SUE: 0.25 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-15.66 | Chg7d=+0.000 | Chg30d=-17.543 | Revisions Net=+0 | Analysts=1
EPS current Year (2026-12-31): EPS=72.17 | Chg7d=+0.000 | Chg30d=+27.373 | Revisions Net=+3 | Growth EPS=+573.9% | Growth Revenue=+3.5%
EPS next Year (2027-12-31): EPS=43.12 | Chg7d=+0.000 | Chg30d=-15.490 | Revisions Net=+1 | Growth EPS=-40.2% | Growth Revenue=-2.3%
[Analyst] Revisions Ratio: +0.60 (4 Up / 1 Down within 30d for Current Year)